Skip to main content
. 2021 Sep 17;13:723871. doi: 10.3389/fnagi.2021.723871

TABLE 1.

Effects of PACAP and IGF-1 on motor neurons and their role in MNDs.

Effects on motor neurons References
IGF-1
Promotion of neuronal survival in vitro and in vivo Ang et al., 1992; Hughes et al., 1993
Enhancing of axonal sprouting Caroni and Grandes, 1990
Protection against excessive glutamate and ischemia Nakao et al., 2001; Vincent et al., 2004
Induction of nerve regeneration Kanje et al., 1989

Effects in MNDs References

Improved motor functions after intrathecal administration in ALS patients Nagano et al., 2005
Improved muscle force, motor coordination and survival in SOD1-G93A ALS mice Saenger et al., 2012; Wang et al., 2018
Reduction of MN degeneration and increase of neuromuscular junction innervation in a SMA mouse model Tsai et al., 2014
Increased muscle fibers hypertrophy and the number of functionally active axonal sprouts in a SMA mouse model Krieger et al., 2014
Improving of motor performances, attenuated weight loss and increased survival in a SBMA mouse model Rinaldi et al., 2012
Amelioration of ionic current defects in a SBMA cell model Jimenez Garduno et al., 2017

Effects on neurons References

PACAP
Promotion of neuronal survival Dejda et al., 2011; Manecka et al., 2013
Induced in damaged neurons Pettersson et al., 2014
Promotion of axonal regeneration Tsuchida et al., 2014
Effects in MNDs
Neuroprotective action on preganglionic parasympathetic and sympathetic neurons in SOD1-G93A ALS mouse model Ringer et al., 2013
Increase of cell survival in a ALS cell model Maugeri et al., 2019
Attenuation of apoptotic signaling in ALS iPSC-derived MNs Bonaventura et al., 2018
MN protection in SBMA cell and mouse model Polanco et al., 2016
Amelioration of ionic current defects in a SBMA cell model Jimenez Garduno et al., 2017; Martinez-Rojas et al., 2021